Posted On: 12/02/2014 3:32:48 PM
Post# of 30067
Experienced CEOs don't put deadlines to things they know can be easily missed especially in the very speculative biotech industry.
But that's to be expected and Gerald looks like he has learned from his past mistakes, at least I hope he has.
Hopefully the launch of Lympro will be the beginning of a great and long bull run for Amarantus.
But that's to be expected and Gerald looks like he has learned from his past mistakes, at least I hope he has.
Hopefully the launch of Lympro will be the beginning of a great and long bull run for Amarantus.
(0)
(0)
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.
